Show simple item record

dc.contributor.authorSova, Milan
dc.contributor.authorKudělka, Miloš
dc.contributor.authorRaška, Milan
dc.contributor.authorMizera, Jan
dc.contributor.authorMikulková, Zuzana
dc.contributor.authorTrajerová, Markéta
dc.contributor.authorOchodková, Eliška
dc.contributor.authorGenzor, Samuel
dc.contributor.authorJakubec, Petr
dc.contributor.authorBoriková, Alena
dc.contributor.authorŠtěpánek, Ladislav
dc.contributor.authorKosztyu, Petr
dc.contributor.authorKriegová, Eva
dc.date.accessioned2022-12-16T10:41:23Z
dc.date.available2022-12-16T10:41:23Z
dc.date.issued2022
dc.identifier.citationViruses. 2022, vol. 14, issue 11, art. no. 2422.cs
dc.identifier.issn1999-4915
dc.identifier.urihttp://hdl.handle.net/10084/149005
dc.description.abstractAnalysing complex datasets while maintaining the interpretability and explainability of outcomes for clinicians and patients is challenging, not only in viral infections. These datasets often include a variety of heterogeneous clinical, demographic, laboratory, and personal data, and it is not a single factor but a combination of multiple factors that contribute to patient characterisation and host response. Therefore, multivariate approaches are needed to analyse these complex patient datasets, which are impossible to analyse with univariate comparisons (e.g., one immune cell subset versus one clinical factor). Using a SARS-CoV-2 infection as an example, we employed a patient similarity network (PSN) approach to assess the relationship between host immune factors and the clinical course of infection and performed visualisation and data interpretation. A PSN analysis of similar to 85 immunological (cellular and humoral) and similar to 70 clinical factors in 250 recruited patients with coronavirus disease (COVID-19) who were sampled four to eight weeks after a PCR-confirmed SARS-CoV-2 infection identified a minimal immune signature, as well as clinical and laboratory factors strongly associated with disease severity. Our study demonstrates the benefits of implementing multivariate network approaches to identify relevant factors and visualise their relationships in a SARS-CoV-2 infection, but the model is generally applicable to any complex dataset.cs
dc.language.isoencs
dc.publisherMDPIcs
dc.relation.ispartofseriesVirusescs
dc.relation.urihttps://doi.org/10.3390/v14112422cs
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.cs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0cs
dc.subjectpatient similarity networkcs
dc.subjectmultivariate data analysiscs
dc.subjectCOVID-19 severitycs
dc.subjectminimal immune signaturecs
dc.subjectdata visualisationcs
dc.subjectIgM and IgG levelscs
dc.titleNetwork analysis for uncovering the relationship between host response and clinical factors to virus pathogen: Lessons from SARS-CoV-2cs
dc.typearticlecs
dc.identifier.doi10.3390/v14112422
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume14cs
dc.description.issue11cs
dc.description.firstpageart. no. 2422cs
dc.identifier.wos000881456000001


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Except where otherwise noted, this item's license is described as © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.